Abstract
Kendomycin, an ansamycin-type natural product first reported in 1996, possesses a series of attractive bioactivities and a unique all-carbon macrocyclic skeleton. To the date, seven total syntheses, two formal total syntheses and a number of synthetic studies on this hot molecule have been reported. In this short review article, we mainly survey and comment on these efforts regarding the difficult macrocyclization strategies.
Original language | English |
---|---|
Pages (from-to) | 203-212 |
Number of pages | 10 |
Journal | Journal of Antibiotics |
Volume | 69 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2016 Apr 1 |